The recent FBI arrests of a married couple, Gladwin and Amelou Gill, have brought attention to the issue of hospice fraud in California. The couple, who co-own 626 Hospice, allegedly defrauded Medicare for $7.45 million while reporting a staggering 97% survival rate for terminal patients. This case highlights a deeper problem within the hospice industry, where fraud is a major concern for both state and federal authorities.
The high survival rate at 626 Hospice is a red flag, as most people enter hospice care in the final stages of a terminal illness. This raises questions about the accuracy of the reported survival rates and the potential for fraudulent billing practices. The FBI's investigation uncovered a pattern of excessive billing and the use of false or stolen identities to collect federal reimbursements for palliative care.
The case of 626 Hospice is not an isolated incident. CBS News has been investigating fraud in the hospice industry in Los Angeles County, and their analysis revealed that over 700 out of 1,800 hospices triggered multiple red flags for fraud. These red flags include low patient counts, excessive billing, shared staff across multiple companies, and supposedly terminally ill patients who were later discharged alive.
The issue of hospice fraud is a nationwide problem, with the Department of Health and Human Services' Office of the Inspector General reporting an estimated $198.1 million in suspected hospice fraud in 2023. This has led to increased scrutiny from Congress, with the House Oversight Committee launching an investigation into 'rampant hospice fraud' in Southern California. The committee is seeking documents related to the state's oversight and internal controls to detect and prevent fraud in federally funded hospice programs.
California's attorney general, Rob Bonta, acknowledges the need for more proactive measures to combat hospice fraud. His office has brought criminal fraud cases against over 100 defendants and filed civil cases, but he emphasizes the importance of addressing the underlying issues. A moratorium on issuing new hospice licenses has been extended to January 2027, as the state works on new emergency regulations and a task force to target the problem.
In my opinion, the case of 626 Hospice and the broader issue of hospice fraud in California highlight the need for increased transparency and accountability in the healthcare industry. It is crucial to address the underlying issues that enable fraud, such as excessive billing and the use of false identities. By taking a comprehensive approach, we can work towards a more ethical and sustainable healthcare system.
